Clinical Characteristics of Taiwanese Children With Congenital Adrenal Hyperplasia Caused by 21-Hydroxylase Deficiency in the Pre-screening Era

Journal of the Formosan Medical Association

Volumn 109, Issue 2, 2010, Pages 148-155

  Lee, Cheng Ting ^a   Tung, Yi Ching ^a   Hsiao, Pei Hung ^a   Lee, Jing Sheng ^a   Tsai, Wen Yu ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

21 hydroxylase deficiency; congenital adrenal hyperplasia; CYP21A2

Indexed keywords

ANDROGEN; BICARBONATE; CHLORIDE; CORTICOTROPIN; HYDROCORTISONE; HYDROXYPROGESTERONE; POTASSIUM; PRASTERONE SULFATE; SODIUM; TESTOSTERONE;

ACNE; ADOLESCENT; ARTICLE; BONE AGE; CHILD; CLINICAL FEATURE; CONGENITAL ADRENAL HYPERPLASIA; CORTICOTROPIN BLOOD LEVEL; DEHYDRATION; FAILURE TO THRIVE; FEEDING DISORDER; FEMALE; GENE DELETION; GENE MUTATION; GENITAL MALFORMATION; GENOTYPE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERKALEMIA; HYPERPIGMENTATION; HYPONATREMIA; INFANT; INFORMATION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEWBORN SCREENING; PHENOTYPE; PHYSICAL DISEASE BY BODY FUNCTION; PREPUBERTY; PRESCHOOL CHILD; SALT WASTING; SCHOOL CHILD; STEROID 21 MONOOXYGENASE DEFICIENCY; TAIWAN; TALL STATURE; TESTOSTERONE BLOOD LEVEL; VIRILIZATION; WEIGHT GAIN;

17-ALPHA-HYDROXYPROGESTERONE; ADRENAL HYPERPLASIA, CONGENITAL; ANDROSTENEDIONE; DEHYDROEPIANDROSTERONE; FEMALE; GENOTYPE; HUMANS; HYDROCORTISONE; HYPONATREMIA; INFANT, NEWBORN; MALE; PHENOTYPE; PIGMENTATION DISORDERS; POINT MUTATION; PREGNANCY; STEROID 21-HYDROXYLASE;

EID: 77649113994     PISSN: None     EISSN: 09296646     Source Type: Journal    
DOI: 10.1016/S0929-6646(10)60035-6     Document Type: Article

References (32)

1. Bongiovanni A.M., and Root A.W. The adrenogenital syndrome. N Engl J Med 268 (1963) 1283-1289
2. White P.C., New M.I., and Dupont B. Congenital adrenal hyper-plasia. N Engl J Med 316 (1987) 1519-1524 1580-6.
3. Dupont B., Oberfield S.E., Smithwick E.M., et al. Close genetic linkage between HLA and congenital adrenal hyperplasia (21-hydroxylase deficiency). Lancet 2 (1977) 1309-1312
4. White P.C., New M.I., and Dupont B. HLA-linked congenital adrenal hyperplasia results from a defective gene encoding a cytochrome P-450 specific for steroid 21-hydroxylation. Proc Natl Acad Sci USA 81 (1984) 7505-7509
5. White P.C., Vitek A., Dupont B., et al. Characterization of frequent deletions causing steroid 21-hydroxylase deficiency. Proc Natl Acad Sci USA 85 (1988) 4436-4440
6. Higashi Y., Tanae A., Inoue H., et al. Aberrant splicing and missense mutations cause steroid 21-hydroxylase [P-450(C21)] deficiency in humans: possible gene conversion products. Proc Natl Acad Sci USA 85 (1988) 7486-7490
7. Amor M., Parker K.L., Globerman H., et al. Mutation in the CYP21B gene (Ile-172-Asn) causes steroid 21-hydroxylase deficiency. Proc Natl Acad Sci USA 85 (1988) 1600-1604
8. Globerman H., Amor M., Parker K.L., et al. Nonsense mutation causing steroid 21-hydroxylase deficiency. J Clin Invest 82 (1988) 139-144
9. Urabe K., Kimura A., Harada F., et al. Gene conversion in steroid 21-hydroxylase genes. Am J Hum Genet 46 (1990) 1178-1186
10. New M.I., Lorenzen F., Lerner A.J., et al. Genotyping steroid 21-hydroxylase deficiency: hormonal reference data. J Clin Endocrinol Metab 57 (1983) 320-326
11. Tsai W.Y., Lee J.S., Hsiao P.H., et al. Genotype of classic congenital adrenal hyperplasia and the 60-minute adrenocor-ticotropic hormone stimulation test. J Formos Med Assoc 94 (1995) 10-13
12. Pang S., Murphey W., Levine L.S., et al. A pilot newborn screening program for congenital adrenal hyperplasia in Alaska. J Clin Endocrinol Metab 55 (1982) 413-420
13. Chu S.Y., Tsai W.Y., Chen L.H., et al. Neonatal screening for congenital adrenal hyperplasia in Taiwan: a pilot study. J Formos Med Assoc 101 (2002) 691-694
14. Schreiner F., Brack C., Salzgeber K., et al. False negative 17-hydroxyprogesterone screening in children with classical congenital adrenal hyperplasia. Eur J Pediatr 167 (2008) 479-481
15. nd ed (1959), Stanford University Press, Stanford
16. Wilson R.C., Wei J.Q., Cheng K.C., et al. Rapid deoxyribonucleic acid analysis by allele-specific polymerase chain reaction for detection of mutations in the steroid 21-hydroxylase gene. J Clin Endocrinol Metab 80 (1995) 1635-1640
17. Ko T.M., Kao C.H., Ho H.N., et al. Congenital adrenal hyper-plasia. Molecular characterization. J Reprod Med 43 (1998) 379-386
18. Tung Y.C., Lee J.S., Tsai W.Y., et al. Physiological changes of adrenal androgens in childhood. J Formos Med Assoc 103 (2004) 921-924
19. White P.C., and Speiser P.W. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 21 (2000) 245-291
20. Speiser P.W., and White P.C. Congenital adrenal hyperplasia. N Engl J Med 349 (2003) 776-788
21. Lebovitz R.M., Pauli R.M., and Laxova R. Delayed diagnosis in congenital adrenal hyperplasia. Need for newborn screening. Am J Dis Child 138 (1984) 571-573
22. Virdi N.K., Rayner P.H., Rudd B.T., et al. Should we screen for congenital adrenal hyperplasia? A review of 117 cases. Arch Dis Child 62 (1987) 659-662
23. Thilén A., and Larsson A. Congenital adrenal hyperplasia in Sweden 1969-1986. Prevalence, symptoms and age at diagnosis. Acta Paediatr Scand 79 (1990) 168-175
24. Kovács J., Votava F., Heinze G., et al. Lessons from 30 years of clinical diagnosis and treatment of congenital adrenal hyperplasia in five middle European countries. J Clin Endocrinol Metab 86 (2001) 2958-2964
25. Tsai W.Y., Hsiao P.H., and Lee J.S. Serum dehydroepiandrosterone sulfate and androstenedione concentrations in children with adrenal disorders. J Formos Med Assoc 97 (1998) 135-138
26. Rösler A., Levine L.S., Schneider B., et al. The interrelationship of sodium balance, plasma renin activity and ACTH in congenital adrenal hyperplasia. J Clin Endocrinol Metab 45 (1977) 500-512
27. Joint LWPES/ESPE CAH Working Group. Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. J Clin Endocrinol Metab 87 (2002) 4048-4053
28. Lee H.H., Chao H.T., Lee Y.J., et al. Identification of four novel mutations in the CYP21 gene in congenital adrenal hyper-plasia in the Chinese. Hum Genet 103 (1998) 304-310
29. Higashi Y., Hiromasa T., Tanae A., et al. Effects of individual mutations in the P-450 (C21) pseudogene on the P-450 (C21) activity and their distribution in the patient genomes of congenital steroid 21-hydroxylase deficiency. J Biochem 109 (1991) 638-644
30. Speiser P.W., Dupont J., Zhu D., et al. Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Invest 90 (1992) 584-595
31. Krone N., Braun A., Roscher A.A., et al. Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive geno-typing in 155 unrelated, well defined patients from southern Germany. J Clin Endocrinol Metab 85 (2000) 1059-1065
32. Dolžan V., Stopar-Obreza M., Žerjav-Tanšek M., et al. Mutational spectrum of congenital adrenal hyperplasia in Slovenian patients: a novel Ala15Thr mutation and Pro30Leu within a larger gene conversion associated with a severe form of the disease. Eur J Endocrinol 149 (2003) 137-144